Works matching IS 20457634 AND DT 2023 AND VI 12 AND IP 22

Results: 36
    1
    2
    3
    4

    Efficacy and safety of the proposed bevacizumab biosimilar BAT1706 compared with reference bevacizumab in patients with advanced nonsquamous non‐small cell lung cancer: A randomized, double‐blind, phase III study.

    Published in:
    Cancer Medicine, 2023, v. 12, n. 22, p. 20847, doi. 10.1002/cam4.6664
    By:
    • Chen, Likun;
    • Rangel, Jose David Gomez;
    • Cil, Timucin;
    • Li, Xingya;
    • Cicin, Irfan;
    • Shen, Yihong;
    • Liu, Zhihua;
    • Ozyilkan, Ozgur;
    • Igor, Bondarenko;
    • Chen, Jun;
    • Oleksandr, Kostiuk;
    • Chen, Zhendong;
    • Zhang, Helong;
    • Fu, Ziyi;
    • Dong, Qingfeng;
    • Song, Shuqiang;
    • Yu, Jin‐Chen;
    • Zhang, Li;
    • Hryhoriy, Adamchuk;
    • Karaoglu, Aziz
    Publication type:
    Article
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25

    Cancer mortality and competing causes of death in older adults with cancer: A prospective, multicentre cohort study (ELCAPA‐19).

    Published in:
    Cancer Medicine, 2023, v. 12, n. 22, p. 20940, doi. 10.1002/cam4.6639
    By:
    • Assouan, Déborah;
    • Paillaud, Elena;
    • Caillet, Philippe;
    • Broussier, Amaury;
    • Kempf, Emmanuelle;
    • Frelaut, Maxime;
    • Brain, Etienne;
    • Lorisson, Emmanuelle;
    • Chambraud, Clelia;
    • Bastuji‐Garin, Sylvie;
    • Hanon, Olivier;
    • Canouï‐Poitrine, Florence;
    • Laurent, Marie;
    • Martinez‐Tapia, Claudia
    Publication type:
    Article
    26
    27

    Impact of the COVID‐19 pandemic on clinical presentation, treatments, and outcomes of new breast cancer patients: A retrospective multicenter cohort study.

    Published in:
    Cancer Medicine, 2023, v. 12, n. 22, p. 20918, doi. 10.1002/cam4.6637
    By:
    • Guével, Etienne;
    • Priou, Sonia;
    • Lamé, Guillaume;
    • Wassermann, Johanna;
    • Bey, Romain;
    • Uzan, Catherine;
    • Chatellier, Gilles;
    • Belkacemi, Yazid;
    • Tannier, Xavier;
    • Guillerm, Sophie;
    • Flicoteaux, Rémi;
    • Gligorov, Joseph;
    • Cohen, Ariel;
    • Benderra, Marc‐Antoine;
    • Teixeira, Luis;
    • Daniel, Christel;
    • Hersant, Barbara;
    • Tournigand, Christophe;
    • Kempf, Emmanuelle
    Publication type:
    Article
    28
    29
    30
    31

    Issue Information.

    Published in:
    Cancer Medicine, 2023, v. 12, n. 22, p. 20657, doi. 10.1002/cam4.4884
    Publication type:
    Article
    32
    33

    The efficacy of molecular targeted therapy and nivolumab therapy for metastatic non‐clear cell renal cell carcinoma: A retrospective analysis using the Michinoku Japan urological cancer study group database.

    Published in:
    Cancer Medicine, 2023, v. 12, n. 22, p. 20677, doi. 10.1002/cam4.6591
    By:
    • Koguchi, Tomoyuki;
    • Naito, Sei;
    • Hatakeyama, Shingo;
    • Numakura, Kazuyuki;
    • Muto, Yumina;
    • Kato, Renpei;
    • Kojima, Takahiro;
    • Kawasaki, Yoshihide;
    • Morozumi, Kento;
    • Kandori, Shuya;
    • Kawamura, Sadafumi;
    • Nishiyama, Hiroyuki;
    • Ito, Akihiro;
    • Habuchi, Tomonori;
    • Obara, Wataru;
    • Ohyama, Chikara;
    • Tsuchiya, Norihiko;
    • Kojima, Yoshiyuki
    Publication type:
    Article
    34
    35

    Prognostic power assessment of clinical parameters to predict neoadjuvant response therapy in HER2‐positive breast cancer patients: A machine learning approach.

    Published in:
    Cancer Medicine, 2023, v. 12, n. 22, p. 20663, doi. 10.1002/cam4.6512
    By:
    • Fanizzi, Annarita;
    • Latorre, Agnese;
    • Bavaro, Domenica Antonia;
    • Bove, Samantha;
    • Comes, Maria Colomba;
    • Di Benedetto, Erika Francesca;
    • Fadda, Federico;
    • La Forgia, Daniele;
    • Giotta, Francesco;
    • Palmiotti, Gennaro;
    • Petruzzellis, Nicole;
    • Rinaldi, Lucia;
    • Rizzo, Alessandro;
    • Lorusso, Vito;
    • Massafra, Raffaella
    Publication type:
    Article
    36